Cargando…
Is There a Role of Targeted Agents in the Management of Adrenocortical Cancers?
Background. Adrenocortical carcinoma (ACC) is a rare and aggressive tumor arising from the adrenal cortex with an incidence of one to two cases per million within the general US population. Recent developments in the understanding of the pathogenesis of ACC have led to multiple clinical trials invol...
Autores principales: | Saif, M. W., Fallon, B., Syrigos, K. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502799/ https://www.ncbi.nlm.nih.gov/pubmed/23198184 http://dx.doi.org/10.1155/2012/875764 |
Ejemplares similares
-
The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series
por: Saif, Muhammad W., et al.
Publicado: (2011) -
Anaesthetic management of a unilateral adrenalectomy of an adrenocortical tumour in a dog
por: Wise, I.K., et al.
Publicado: (2016) -
A case of metastatic adrenocortical carcinoma
por: Kuthiah, N, et al.
Publicado: (2019) -
Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022) -
Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma
por: Mohammad, Mustafa M., et al.
Publicado: (2013)